Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Genetics Q3 Revenues Rise on Strong Biopharma Services Performance

NEW YORK (GenomeWeb) – Cancer Genetics today announced a 24 percent jump in its third quarter revenues on strong performance in its biopharma services business.

For the three-month period ended Sept. 30, the Rutherford, New Jersey-based cancer diagnostics firm reported revenues of $4 million compared with $3.2 million in the same period last year, matching analysts' consensus estimate. Biopharma services revenues increased 35 percent to $2.6 million from $1.9 million, offsetting a $100,000 decline in clinical services revenue to $1.1 million.

Company highlights during the quarter included signing coverage deals with Illinois Blue Cross Blue Shield, as well as provider agreements with Blue Cross Blue Shield (BCBS) of North Carolina, BCBS Nebraska, and WellMark.

"There is continued high demand for our unique, proprietary portfolio of genomic tests and panels in the marketplace, and our focused M&A strategy has delivered three transformative acquisitions over the past two years," Cancer Genetics President and CEO Panna Sharma said in a statement.

Last month, Cancer Genetics closed its $14 million purchase of Response Genetics. In 2014, it acquired Gentris and Bioserve for $6.25 million and $1.9 million, respectively. 

Cancer Genetics' net loss in the third quarter rose to $5.2 million, or $.56 a share, from $4.8 million, or $.51 a share, in the year-ago quarter, missing Wall Street's estimate of a loss per share of $.49.

Third quarter R&D costs climbed to $1.8 million from $1.4 million, while SG&A expenses increased to $4.7 million from $4.2 million in Q3 2014.

At the end of the quarter, Cancer Genetics had cash and cash equivalents totaling $19.9 million. Earlier this month, the company said that it anticipates grossing $12 million in a public offering of stock that it launched last week.

In early Tuesday morning trading on the Nasdaq, shares of Cancer Genetics were up 1 percent at $3.87.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.